Aeolus Pharmaceuticals Inc. reported consolidated unaudited earnings results for the second quarter and six months ended March 31, 2015. For the quarter, the company reported contract revenue of $1,189,000 compared with $1,438,000 for the same period last year. Loss from operations was $712,000 compared with $437,000 for the same period last year. Net loss was $712,000 or $0.01 diluted per share compared with $437,000 for the same period last year.

For the six months, the company reported contract revenue of $2,114,000 compared with $2,231,000 for the same period last year. Loss from operations was $1,410,000 compared with $1,132,000 for the same period last year. Net loss was $1,410,000 or $0.01 diluted per share compared with $1,132,000 or $0.01 diluted per share for the same period last year. Net cash used in operating activities was $1,269,000 compared with $349,000 for the same period last year.